Market Currents
Body Central (BODY +2.5%) has a recession-resistant business model and should be bought at...
-
Tuesday, February 14, 2012, 12:24 PM ETBody Central (BODY +2.5%) has a recession-resistant business model and should be bought at current levels, says Oppenheimer. The firm raises its target price on the stock to $31 from $27.
Other date
Latest Articles
